Advertisement · 728 × 90
#
Hashtag
#Anaemia
Advertisement · 728 × 90
Post image

Preoperative #anaemia is common even amongst healthy children. Incorporating simple, feasible Hb assessment into routine pre-op assessment is an important step in optimisation #OpenAccess

www.bjaopen.org/article/S2772-6096(26)00...

1 0 0 0
Post image

#NATA26 | 29 April–2 May | Bilbao🇪🇸

PBM Implementation Workshop
Practical strategies to implement & sustain #PBM programmes:
#Anaemia management
• (Anti-) #coagulation
• PBM in practice
Interactive round tables+ real-world case discussion

Registration
👉 nataonline.com/annual-sympo...

0 0 0 0

Can results be trusted?
Despite some limits, the study was stronger than older ones. Updated anaemia levels are based on consistent results from healthy people. Changing anaemia’s definition doesn’t just shift numbers, it redefines who gets care ❤️‍🩹. 🔗NHS patient information on anaemia #Anaemia

0 0 0 0
Preview
Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency Background and Objectives Iron deficiency (ID), with or without anaemia, affects over 1 billion people globally. Early detection is essential, but current diagnostic tools may be costly, logisticall.....

New research in #VoxSanguinis explores low haemoglobin density (LHD%) as a no-added-cost marker for screening iron deficiency.

Accessible, scalable, and derived from routine CBC data.

🔗 onlinelibrary.wiley.com/doi/full/10....

#Haematology #IronDeficiency #Anaemia

0 0 0 0

Thanks @natrevendo.nature.com & Claire Greenhill for highlighting our work 🙏🌸

📣 Are you a #nephrologist prescribing #Roxadustat for #anaemia in #CKD ?
👉 We would love to hear from you and assess if these mouse findings may be effective in humans too! Contact me ✅
Link to original paper: see comment

2 1 1 0
Post image

#Secondaryanalysis of #PABST-BR showed #multiintervention #anaemia treatment results in higher #haemoglobin and #ferritin values post-hospitalisation

www.bjanaesthesia.org/article/S0007-0912(25)00...

0 0 0 0
Post image

Pre-operative anaemia and mortality: a reply

#AnSky #MedSky #anaemia

doi.org/10.1111/anae...

2 1 0 0
Post image

Perioperative #anaemia is a known risk factor for adverse outcomes in #cardiac surgery. Evidence focuses on pre-op Hb, but post-op Hb drop is also associated with increased risk of 30-day mortality and major morbidity www.bjaopen.org/article/S2772-6096(25)00...

6 2 1 0
Prevalence of anaemia in Africa among vulnerable groups.

Prevalence of anaemia in Africa among vulnerable groups.

Prospective of indigenous #African wild food #plants in alleviation of the severe iron deficiency #anaemia in Sub-Saharan Africa

Review by Eltayb Abdellatef, Yohannes Gedamu Gebre and Petra Bauer

@botanyhhu.bsky.social

nph.onlinelibrary.wiley.com/doi/10.1002/...

3 1 0 0
Preview
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Mal... Over 1 year of follow-up after the third vaccine dose, vaccination with RTS,S/AS01E in real-world settings showed significant reductions in malaria burden. These findings reinforce the continued use o...

In a study of 45,000 children across Ghana 🇬🇭, Kenya 🇰🇪, and Malawi 🇲🇼, researchers compared #vaccinated kids 💉 (after 3 doses) with their unvaccinated peers.
The vaccinated children had:
🦟 30% less malaria
🏥 58% less severe #malaria
🛏️ Fewer malaria-related hospitalisations
🩸 Less #anaemia

3 0 0 0
Preview
New clinical tool could identify women most at risk of dying in childbirth  » The Blood Trials New clinical tool could identify women most at risk of dying in childbirth  »

🆕study, led by @lshtm.bsky.social & @unil.bsky.social, develops a simple tool to predict which women are most at risk of death or near-miss from bleeding in childbirth.

Using admission data, including #anaemia as a risk factor, it could help clinicians intervene earlier & save lives

bit.ly/3Okg1ms

4 2 0 0
Post image

#NATA26 | Bilbao 🇪🇸 | 29 April–2 May

Accredited with up to 17.5 ECMEC® credits.

Structured, accredited scientific exchange in #PBM, #anaemia, #bleeding and #thrombosis.

👉 Register now:
nataonline.com/annual-sympo...

0 0 0 0
Post image

#NATA26 | 29 April–2 May | Bilbao 🇪🇸
Wednesday 17:00 — be in the room!

High-level review of the most influential recent publications in #anaemia #bleeding & #thrombosis
Vernon #Louw 🇿🇦
Thorsten #Haas 🇺🇸
Marc #Samama 🇫🇷

Early bird registration 09 March
👉 nataonline.com/annual-sympo...

0 0 0 0
Preview
Transfusion Evidence Library The Transfusion Evidence Library is a database of systematic reviews (since 1980) and randomised controlled trials (since 1950) relevant to transfusion medicine. It is fully searchable, updated monthl...

🩸World Anaemia Awareness Day is observed annually on the 13th of February 🩸

Find out more about #anaemia with the #Transfusion Evidence Library:
www.transfusionevidencelibrary.com

Or listen again to the episode 3 of the #TalkingTransfusion podcast:
open.spotify.com/episode/2B7P...

#MedSky

2 1 0 0
Post image

🩸Did you know #IronDeficiency (ID) is the most common cause of #anaemia & the most prevalent of micronutrient deficiencies 🌍?

Today is World Anaemia Awarenss Day

Preventing & treating ID & anaemia are global health priorities, especially for the most affected—women!

Learn more👇🏻about our work

2 1 0 0
Post image Post image Post image

Treating #iron deficiency before #anaemia occurs is essential for a good quality of life. Recognising the influence of inflammation on the body's ability to absorb iron & taking a full view and treating is important #EAHAD2026

0 1 0 0
Preview
Attitudes of medical doctors and pharmacists towards the pharmacological management of anemia in critically ill patients We are contacting you to request your participation in a study aimed at gaining insights into anemia management in survivors of critical illness. 1. Research Title and Ethics Committee Approval The title of this survey is "Attitudes of medical doctors and pharmacists towards the pharmacological management of anemia in critically ill patients". This research has been reviewed by the Epidemiological Research Ethics Committee of Hiroshima University and approved by the Director of Hiroshima University. 2. Research Collaborating Institutions and Principal Investigator This survey is being conducted with the collaboration of Dr. Yuki Kataoka (Nagoya University), Dr. Richard Bourne (University of Manchester), Dr. Cathrine McKenzie (University of Southampton), Dr. Kent Doi (The University of Tokyo Hospital), Dr. Simon Oczkowski and Dr. Joanna Dionne (McMaster University), and Dr. Alexander Vlaar (Amsterdam University Medical Centers). 3. Research Purpose and Significance The purpose of this study is to explore the knowledge, attitudes, and clinical practices of medical doctors and pharmacists regarding the pharmacological management of anemia in critically ill patients. Anemia is a frequent condition in Intensive Care Unit (ICU) patients, often persisting after discharge and leading to various complications such as readmission and mortality. Although “Erythropoiesis-stimulating agents (ESA) and Hypoxia-inducible factor prolyl-4-hydroxylase inhibitors (HIF-PHI)” has been proposed, their clinical adoption remains limited due to uncertainty including unclear patient selection criteria. Therefore, by identifying current clinical perspectives and practices, this survey aims to clearly barriers to implementation and contribute to the development of more effective and evidence-informed anemia management strategies in the ICU setting. 4. Research Method and Period This study is a scenario-based questionnaire survey. The research period is from the date of ethics approval to December 31, 2026. The response period for the questionnaire is set at six months from the initial survey recruitment email. This survey takes approximately 20 minutes to complete. The information obtained will be used only for research purposes and be shared and analyzed with Nagoya University. 5. Reason for Selection as Research Subjects This study targets medical doctors or pharmacists who have experience managing or have managed critically ill patients (excluding post-operative patients) admitted to the ICU. The medical doctors and pharmacist members of these societies match the criteria of the research. 6. Burdens, Anticipated Risks, and Benefits for Research Subjects Burden: Approximately 15 minutes required to complete the questionnaire. Risk: Possibility of personal information leakage if email addresses contain personal information. As a countermeasure, email addresses will be immediately deleted during data compilation. Benefit: While there are no direct benefits, participants can contribute to improving pharmacological treatments of anemia in critically ill patients. 7. Consent and Withdrawal By responding to the questionnaire, you are considered to have consented to participate in this study. Consent can be withdrawn even after responding, as long as it's before data compilation. There are no disadvantages for not consenting or withdrawing consent. 8. Method of Disclosing Research Information The results of this study will be made public through paper submissions and conference presentations. 9. Method of Obtaining/Viewing Research Protocol The research protocol and materials related to research methods can be obtained or viewed to the extent that it does not compromise personal information protection and research originality. If you wish to do so, please contact us using the contact information below. 10. Handling of Personal Information Collected information will be processed and analyzed in a form that cannot identify individuals. 11. Storage and Disposal of Information Collected information will be stored for 5 years after the end of the research and then appropriately disposed of. 12. Research Funding Source and Conflicts of Interest This research is conducted with the university's operational grants, and the researchers have no conflicts of interest. 13. Handling of Research Results Research results will be anonymized and statistically analyzed. Individual results will not be disclosed. 14. Response to Inquiries Questions and inquiries about the research will be addressed at the following contact. Details of the research plan are published at the following link: https://osf.io/6b94z/ Sincerely, Shodai Yoshihiro, Mitsuaki Nishikimi, Nobuaki Shime, Hiroaki Matsuo Hiroshima University Hospital shodaidotet@gmail.com

🔬 New #ESICMSurvey! Share your views on 𝗮𝗻𝗮𝗲𝗺𝗶𝗮 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗜𝗖𝗨. Doctors & pharmacists, help us explore knowledge, attitudes & practices to improve care.

✔️ Approved by ESICM Pharma & APM Sections & Transfusion Task Force

🔗 Take the survey 👉 shorturl.at/GCFrh

#ESICM #ICU #Survey #Anaemia

1 0 0 0
Title: Over half of all women in India were anaemic as of 2021

Sub-title: Map showing prevalence of anaemia among women aged 15–49 in India, by state (2021)

Explanation: A choropleth map of India where each state is shaded from light to dark purple to show the share of women aged 15–49 who are anaemic. Darker states represent higher prevalence, with West Bengal indicated as having the highest incidence. A note highlights that even richer states such as Gujarat have about two in three women who are anaemic. At the bottom, text defines anaemia as haemoglobin below 12.0 g/dl.

Source: National Family Health Survey 5 (2019–21), IIPS

Attribution: Data For India | CC BY

Title: Over half of all women in India were anaemic as of 2021 Sub-title: Map showing prevalence of anaemia among women aged 15–49 in India, by state (2021) Explanation: A choropleth map of India where each state is shaded from light to dark purple to show the share of women aged 15–49 who are anaemic. Darker states represent higher prevalence, with West Bengal indicated as having the highest incidence. A note highlights that even richer states such as Gujarat have about two in three women who are anaemic. At the bottom, text defines anaemia as haemoglobin below 12.0 g/dl. Source: National Family Health Survey 5 (2019–21), IIPS Attribution: Data For India | CC BY

🧵 Over half of all women aged 15-49 in India were anaemic as of 2021, according to the National Family Health Survey’s (NFHS) 5th round.

#Women #Children #Anaemia #Health #India #DataForIndia

0 0 1 0
Post image

🚨📢10 more days to be part of #NATA26
🗓 New deadline: 26 January

Present your research. Advance #PBM worldwide.
✔️ Share your work with international experts
✔️ Compete for Best #Abstract
✔️ Young NATA #Scholarships available

🔗 nataonline.com/annual-sympo...

#anaemia #coagulation

0 0 0 0
Post image

NATA26 I 29 April - 2 May I Bilbao 🇪🇸

Wake-up call. Time to stop snoozing.
It’s the LAST weekend before #NATA26 DEADLINES:

#Abstract submission & Young NATA Scholarships
FRIDAY 16 JANUARY | 23:59 CET

👉 nataonline.com/annual-sympo...

#PBM #Haemostasis #Thrombosis #Anaemia #Iron

0 0 0 0
A woman is examined after childbirth at Holy Family Hospital, Rawalpindi, Pakistan. Credit: Saiyna Bashir, Wellcome Trust

A woman is examined after childbirth at Holy Family Hospital, Rawalpindi, Pakistan. Credit: Saiyna Bashir, Wellcome Trust

🆕study suggests episiotomy, a surgical cut during childbirth, doubles risk of severe bleeding in women with moderate or severe #anaemia.

Data from the WOMAN Trials could better inform routine practices to prevent bad outcomes during #childbirth.

👇
www.lshtm.ac.uk/newsevents/n...

6 1 0 1
Post image

#Abstracts received from across the world — and a strong #NATA26 programme is taking shape.

⏳ Abstract deadline: 16 Jan | 23:59 CET
📍 Bilbao | 29 Apr–2 May 2026

Don’t miss the chance to contribute 👉
nataonline.com/annual-sympo...

#PBM #Haemostasis #Thrombosis #anaemia #coagulation

0 0 0 0
Preview
Hutchmed scores with drug for rare autoimmune disease Hutchmed is preparing to file for approval of its drug for the rare disorder wAIHA in China, after chalking up a win in a pivotal phase 2/3 trial

#Hutchmed is preparing to file for approval of a drug for the rare #autoimmune disorder warm antibody autoimmune haemolytic #anaemia (#wAIHA) in #China, after chalking up a win in a pivotal phase 2/3 trial.

pharmaphorum.com/news/hutchme...

0 0 0 0
Post image

The final #NATA Scientific Newsletter of the year is online.
Time to slow down, re-source your energy, and catch up on #research you may have missed.

Subscribe to stay up to date 👉 nataonline.com/scientific-n...

#PBM #Thrombosis #Haemostasis #Fluids #Anaemia

0 0 0 0

#anaemiabrasil #borboletando #edtwt #thinspo #anamia #anaemia #butterflyana #borboletana #prettygirlsdonteat #controlana #casuloana #askanamia #anorexia #anabrasil #anatriger #nofood #deathspo

1 0 1 0

Persistent postoperative anaemia and 1-year mortality: re-examining time origin and sample selection – a reply

#AnSky #anaemia

0 0 0 0

Pre-operative anaemia, red blood cell transfusion and mortality after cardiac surgery: a Netherlands Heart Registration mediation analysis

#AnSky #MedSky #anaemia

doi.org/10.1111/anae...

0 0 0 0
Post image

Pre-operative anaemia is an established risk factor for mortality after cardiac surgery.

To what extent is this risk mediated by complications related to red blood cell transfusion?

#AnSky #HemeSky #MedSky #anaemia

doi.org/10.1111/anae...

2 1 0 0

@anniegirl.bsky.social @luciecatnip.bsky.social As usual, as the first Tuesday of the month looms, I'm debating whether I should do the Great Grocery Shop in person, or not. 🤔 It's exhausting & my #Anaemia is making a comeback, & I don't know why.🙄

0 0 0 0
Post image

NATA26🇪🇸- Bilbao Snapshots
✨ Guggenheim glow ✨
The museum’s titanium panels shift colour with the light — one of Bilbao’s many surprises.

Join us there for #NATA26 (29 Apr–2 May 2026)!
Registration & abstracts now open
#Bilbao #PBM #Haemostasis #Anaemia #Transfusion #PBM #iron

0 0 0 0